Predicting Live Birth, Preterm Delivery, and Low Birth Weight in Infants Born from In Vitro Fertilisation: A Prospective Study of 144,018 Treatment Cycles
Background:
The extent to which baseline couple characteristics affect the probability of live birth and adverse perinatal outcomes after assisted conception is unknown.
Methods and Findings:
We utilised the Human Fertilisation and Embryology Authority database to examine the predictors of live birth in all in vitro fertilisation (IVF) cycles undertaken in the UK between 2003 and 2007 (n = 144,018). We examined the potential clinical utility of a validated model that pre-dated the introduction of intracytoplasmic sperm injection (ICSI) as compared to a novel model. For those treatment cycles that resulted in a live singleton birth (n = 24,226), we determined the associates of potential risk factors with preterm birth, low birth weight, and macrosomia. The overall rate of at least one live birth was 23.4 per 100 cycles (95% confidence interval [CI] 23.2–23.7). In multivariable models the odds of at least one live birth decreased with increasing maternal age, increasing duration of infertility, a greater number of previously unsuccessful IVF treatments, use of own oocytes, necessity for a second or third treatment cycle, or if it was not unexplained infertility. The association of own versus donor oocyte with reduced odds of live birth strengthened with increasing age of the mother. A previous IVF live birth increased the odds of future success (OR 1.58, 95% CI 1.46–1.71) more than that of a previous spontaneous live birth (OR 1.19, 95% CI 0.99–1.24); p-value for difference in estimate <0.001. Use of ICSI increased the odds of live birth, and male causes of infertility were associated with reduced odds of live birth only in couples who had not received ICSI. Prediction of live birth was feasible with moderate discrimination and excellent calibration; calibration was markedly improved in the novel compared to the established model. Preterm birth and low birth weight were increased if oocyte donation was required and ICSI was not used. Risk of macrosomia increased with advancing maternal age and a history of previous live births. Infertility due to cervical problems was associated with increased odds of all three outcomes—preterm birth, low birth weight, and macrosomia.
Conclusions:
Pending external validation, our results show that couple- and treatment-specific factors can be used to provide infertile couples with an accurate assessment of whether they have low or high risk of a successful outcome following IVF.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Predicting Live Birth, Preterm Delivery, and Low Birth Weight in Infants Born from In Vitro Fertilisation: A Prospective Study of 144,018 Treatment Cycles. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000386
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000386
Souhrn
Background:
The extent to which baseline couple characteristics affect the probability of live birth and adverse perinatal outcomes after assisted conception is unknown.
Methods and Findings:
We utilised the Human Fertilisation and Embryology Authority database to examine the predictors of live birth in all in vitro fertilisation (IVF) cycles undertaken in the UK between 2003 and 2007 (n = 144,018). We examined the potential clinical utility of a validated model that pre-dated the introduction of intracytoplasmic sperm injection (ICSI) as compared to a novel model. For those treatment cycles that resulted in a live singleton birth (n = 24,226), we determined the associates of potential risk factors with preterm birth, low birth weight, and macrosomia. The overall rate of at least one live birth was 23.4 per 100 cycles (95% confidence interval [CI] 23.2–23.7). In multivariable models the odds of at least one live birth decreased with increasing maternal age, increasing duration of infertility, a greater number of previously unsuccessful IVF treatments, use of own oocytes, necessity for a second or third treatment cycle, or if it was not unexplained infertility. The association of own versus donor oocyte with reduced odds of live birth strengthened with increasing age of the mother. A previous IVF live birth increased the odds of future success (OR 1.58, 95% CI 1.46–1.71) more than that of a previous spontaneous live birth (OR 1.19, 95% CI 0.99–1.24); p-value for difference in estimate <0.001. Use of ICSI increased the odds of live birth, and male causes of infertility were associated with reduced odds of live birth only in couples who had not received ICSI. Prediction of live birth was feasible with moderate discrimination and excellent calibration; calibration was markedly improved in the novel compared to the established model. Preterm birth and low birth weight were increased if oocyte donation was required and ICSI was not used. Risk of macrosomia increased with advancing maternal age and a history of previous live births. Infertility due to cervical problems was associated with increased odds of all three outcomes—preterm birth, low birth weight, and macrosomia.
Conclusions:
Pending external validation, our results show that couple- and treatment-specific factors can be used to provide infertile couples with an accurate assessment of whether they have low or high risk of a successful outcome following IVF.
: Please see later in the article for the Editors' Summary
Zdroje
1. Nyboe AndersenA
GoossensV
BhattacharyaS
FerrarettiAP
KupkaMS
2009 Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 24 1267 1287
2. Centers for Disease Control and Prevention ASfRM, Society for Assisted Reproductive Technology 2008 2006 Assisted reproductive technology success rates: National summary and fertility clinic reports. Atlanta: CDC. Available: http://www.cdc.gov/art/art2006/index.htm. Accessed: 30 November 2010
3. Australian Government Department of Health and Ageing 2006 Report of the independent review of assisted reproductive technologies. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/ART-Report. Accessed: 30 November 2010
4. LeushuisE
van der SteegJW
SteuresP
BossuytPMM
EijkemansMJC
2009 Prediction models in reproductive medicine: A critical appraisal. Hum Reprod Update 15 537 552
5. StolwijkAM
ZielhuisGA
HamiltonCJCM
StraatmanH
HollandersJMG
1996 Pregnancy: Prognostic models for the probability of achieving an ongoing pregnancy after in-vitro fertilization and the importance of testing their predictive value. Hum Reprod 11 2298 2303
6. StolwijkAM
StraatmanH
ZielhuisGA
JansenCA
BraatDD
1998 External validation of prognostic models for ongoing pregnancy after in- vitro fertilization. Hum Reprod 13 3542 3549
7. TempletonA
MorrisJK
ParslowW
1996 Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348 1402 1406
8. HunaultCC
EijkemansMJ
PietersMH
te VeldeER
HabbemaJD
2002 A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril 77 725 732
9. HunaultCC
te VeldeER
WeimaSM
MacklonNS
EijkemansMJ
2007 A case study of the applicability of a prediction model for the selection of patients undergoing in vitro fertilization for single embryo transfer in another center. Fertil Steril 87 1314 1321
10. EversJL
2002 Female subfertility. Lancet 360 151 159
11. WHO 2002 Current practices and controversies in assisted reproduction: Report of a WHO Meeting.
VayenaE
RowePJ
GriffinPD
Medical, Ethical and Social Aspects of Assisted Reproduction Geneva WHO Publications 381 396
12. MinJK
BrehenySA
MacLachlanV
HealyDL
2004 What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: The BESST endpoint for assisted reproduction. Hum Reprod 19 3 7
13. BarkerDJ
Fetal and Infant origins of Adult Disease. London 1992 Publisher British Medical JournalISBN 978-0-7279-0743-1
14. JacksonRA
GibsonKA
WuYW
CroughanMS
2004 Perinatal outcomes in singletons following in vitro fertilization: A meta-analysis. Obstet Gynecol 103 551 563
15. AllenVM
WilsonRD
CheungA
2006 Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 28 220 250
16. DraperES
KurinczukJJ
AbramsKR
ClarkeM
1999 Assessment of separate contributions to perinatal mortality of infertility history and treatment: A case-control analysis. Lancet 353 1746 1749
17. RomundstadLB
RomundstadPR
SundeA
von DuringV
SkjaervenR
2008 Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: A population-based cohort study. Lancet 372 737 743
18. BassoO
BairdDD
2003 Infertility and preterm delivery, birthweight, and caesarean section: A study within the Danish National Birth Cohort. Hum Reprod 18 2478 2484
19. NygrenKG
FinnstromO
KallenB
OlaussonPO
2007 Population-based Swedish studies of outcomes after in vitro fertilisation. Acta Obstet Gynecol Scand 86 774 782
20. von ElmE
AltmanDG
EggerM
PocockSJ
GøtzschePC
2007 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370 1453 1457
21. DeLongER
DeLongDM
Clarke-PearsonDL
1988 Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44 837 845
22. PencinaMJ
D'AgostinoRBSr
D'AgostinoRBJr
VasanRS
2008 Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 27 157 172
23. SmeenkJMJ
StolwijkAM
KremerJAM
BraatDDM
2000 External validation of the Templeton model for predicting success after IVF. Hum Reprod 15 1065 1068
24. PalermoG
JorisH
DevroeyP
Van SteirteghemAC
1992 Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340 17 18
25. Mook-KanamoriDO
SteegersEA
EilersPH
RaatH
HofmanA
2010 Risk factors and outcomes associated with first-trimester fetal growth restriction. JAMA 303 527 534
26. SmithGC
SmithMF
McNayMB
FlemingJE
1998 First-trimester growth and the risk of low birth weight. N Engl J Med 339 1817 1822
27. BukowskiR
SmithGCS
MaloneFD
BallRH
NybergDA
2007 Fetal growth in early pregnancy and risk of delivering low birth weight infant: Prospective cohort study. BMJ 334 836-
28. ColditzGA
WillettWC
StampferMJ
RosnerB
SpeizerFE
1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316 1105 1110
29. van der SchouwYT
van der GraafY
SteyerbergEW
EijkemansJC
BangaJD
1996 Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 714 718
30. CooleyM
BakalovV
BondyCA
2003 Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 290 2127 2128
31. RedmanCW
SargentIL
2003 Pre-eclampsia, the placenta and the maternal systemic inflammatory response–A review. Placenta 24 Suppl A S21 27
32. BodriD
VernaeveV
FiguerasF
VidalR
GuillenJJ
2006 Oocyte donation in patients with Turner's syndrome: A successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Hum Reprod 21 829 832
33. PaulsonRJ
BoostanfarR
SaadatP
MorE
TourgemanDE
2002 Pregnancy in the sixth decade of life: Obstetric outcomes in women of advanced reproductive age. JAMA 288 2320 2323
34. VillamorE
CnattingiusCnattingius
Interpregnancy weight change and risk of adverse pregnancy outcomes: A population-based study. Lancet 368 1164 1170
35. MorrisonJJ
RennieJM
MiltonPJ
1995 Neonatal respiratory morbidity and mode of delivery at term: Influence of timing of elective caesarean section. Br J Obstet Gynaecol 102 101 106
36. StutchfieldP
WhitakerR
RussellI
2005 Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: Pragmatic randomised trial. BMJ 331 662
37. Nyboe AndersenA
GoossensV
FerrarettiAP
BhattacharyaS
FelberbaumR
2008 Assisted reproductive technology in Europe, 2004: Results generated from European registers by ESHRE. Hum Reprod 23 756 771
38. CraftI
FormanR
1997 Analysis of IVF data. Lancet 349 284
39. JohnsonN
van VoorstS
SowterMC
StrandellA
MolBW
2010 Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev CD002125
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies